Clinical Trials Directory

Trials / Completed

CompletedNCT00893139

A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
765 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.

Conditions

Interventions

TypeNameDescription
DRUGAL-38583 ophthalmic solution 0.05%
DRUGAL-38583 ophthalmic solution 0.10%
DRUGAL-38583 vehicleInactive ingredients used as a placebo comparator

Timeline

Start date
2009-06-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2009-05-05
Last updated
2014-07-15

Source: ClinicalTrials.gov record NCT00893139. Inclusion in this directory is not an endorsement.